Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
13.10
-0.15 (-1.13%)
At close: Aug 8, 2025, 4:00 PM
12.95
-0.15 (-1.15%)
After-hours: Aug 8, 2025, 7:55 PM EDT
Accolade Market Cap
Stoke Therapeutics has a market cap or net worth of $715.22 million as of August 8, 2025. Its market cap has decreased by -3.90% in one year.
Market Cap
715.22M
Enterprise Value
339.12M
1-Year Change
-3.90%
Ranking
Category
Stock Price
$13.10
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has decreased from $804.46M to $715.22M, a decrease of -11.09%. That is a compound annual growth rate of -1.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 715.22M | 22.42% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | 2.24B | 142.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.04B |
| Johnson & Johnson | 410.84B |
| AbbVie | 346.78B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 227.88B |
| UnitedHealth Group | 222.96B |
| Novartis AG | 221.76B |
| Novo Nordisk | 200.63B |